Phase 1
Completed N=28
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
Source: ClinicalTrials.gov NCT00985829 ↗Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Dec 2009
Primary outcomePrimary: Clinical Response to Photodynamic Therapy — 9; 14; 5 lesions
Summary
The purpose of this study is to evaluate the efficacy of pdt in treatment of bcc and factors that affect response rate.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Response to Photodynamic Therapy |
9; 14; 5 | — |
| SECONDARY Histologic Resolution of Lesion |
3; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Histologically proven BCCs
Exclusion Criteria
- rodent ulcer
- morphea type
- ANA +
- history of photosensitivity or photodermatosis or ingestion of phototoxic drugs during last month
- pregnancy
- breast feeding
- age< 18
- history of another therapeutic intervention for bcc during last 6 months
Data sourced from ClinicalTrials.gov (NCT00985829). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.